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ABSTRACT
Infants react sensible to dietary changes because the gut physiology and functionality is not fully mature. The 
first few months of life is the 'window of opportunity' for optimal physical growth and development, cognitive 
development, and emotional and social development. Exclusive breastfeeding is recommended for the first 6 
months of life. Breast milk is important for the maturation of the infant’s digestive system. Potentially protective 
factors are present in higher amounts in feces from breast-fed infant than from formula-fed infants. The amount of 
intestinal bifidobacteria in breastfed infants is higher than in formula-fed babies. Mother's milk protects against 
infection because it contains different factors with immologic properties. The differences in protein fractions 
between human and cow milk are impressive. The human milk oligosaccharides are the third most important 
nutritional component are fermented in the colon, making the environment in the colon suitable for the growth 
of bifidobacteria and lactobacillus. 
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ABSTRAK
Bayi bereaksi sensitif terhadap perubahan pola makan karena fisiologi dan fungsi usus yang belum sepenuhnya 
matang. Beberapa bulan pertama kehidupan adalah 'window of opportunity' untuk pertumbuhan fisik dan 
perkembangan optimal, perkembangan kognitif, serta perkembangan emosional dan sosial. Pemberian air 
susu ibu (ASI) eksklusif dianjurkan untuk 6 bulan pertama kehidupan. ASI penting untuk pematangan sistem 
pencernaan bayi. Faktor yang berpotensi protektif hadir dalam jumlah yang lebih tinggi pada feses bayi yang 
diberi ASI daripada bayi yang diberi susu formula. Jumlah bifidobakteri usus pada bayi yang diberi ASI lebih 
tinggi daripada bayi yang diberi susu formula. Air susu ibu melindungi dari infeksi karena mengandung faktor 
yang berbeda, adanya sifat imologis. Perbedaan fraksi protein antara ASI dan susu sapi sangat mengesankan. 
Oligosakarida susu manusia adalah komponen nutrisi terpenting ketiga yang difermentasi di usus besar, membuat 
lingkungan di usus besar cocok untuk pertumbuhan bifidobakteri dan lactobacillus.
Kata kunci: menyusui, air susu ibu (ASI), window of opportunity, perlindungan usus, pertumbuhan optimal
INTRODUCTION
Human milk is the first choice infant feeding. The 
exclusive breastfed infant with a normally diversified 
maternal dietary intake is the gold standard. Before 
2001, the World Health Organization (WHO) 
recommended that infants be exclusively breastfed for 
4-6 months with the introduction of complementary 
foods (any fluid or food other than breast milk). 
Thereafter, in 2001, after a systematic review and 
expert consultation, this advice was changed and 
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exclusive breastfeeding is now recommended for the 
first 6 months of life.1 
Many data showed that formule feeding increased 
the incidence of cow's milk protein allergy (CMPA) or 
atopic manifestation compared to breastfeeding (short-
term prevention). The long-term benefit of a reduced 
inidence of atopic disease, cardio-vascular disease, and 
other diseases are still on going study. 
Window of Opportunity
A window of opportunity is a period of time during 
which an intervention will result in short and long 
term benefit, and is thus a critical period. The first 
few months of life is the 'window of opportunity' for; 
(1) Optimal physical growth and development (e.g. 
weight and height gain); (2) Cognitive development 
(e.g. language, non-verbal learning, attention, problem 
solving, IQ); (3) Emotional and social development 
(e.g. emotional control, behavioral adaptation, social 
interaction). 
Infants react sensible to dietary changes because the 
gut physiology and functionality is not fully mature. 
The mucosa of the gut is not yet fully closed (relative 
absence of „tight junctions“); therefore large molecules 
such as intact proteins, (pathogenic) bacteria pass 
relatively easy through the small intestinal mucosa into 
the bloodstream. The immune system is not yet fully 
developped as well. The first few months of life is a 
vulnerable period, in which a child’s immature immune 
system is constantly exposed to over one billion of 
germs.2 Children with a poor immune system will be 
more vulnerable to infection, including respiratory tract 
infection, otitis media and gastroenteritis. An infant 
that suffers frequent infections will miss the window 
of opportunity to develop its full potential.2
Suboptimal Exclusive Breastfeeding 
Non-exclusive breastfeeding is associated with an 
increased risk for many diseases such as necrotizing 
enterocolitis, otitis media, gastroenteritis, lower 
respiratory tract infections, atopic dermatitis, sudden 
infant death syndrome, childhood asthma, leukemia, 
type 1 diabetes mellitus and childhood obesity. 
A socio-economic analysis concluded that the 
burden of suboptimal breastfeeding is enormous: if 90% 
of all families could comply with the recommendation 
to breastfeed exclusively for 6 months in the USA, 
this would result for the government in savings of 13 
billion dollars per year on health care cost and prevent 
almost a thousand infant deaths.3
Optimal Growth
Exclusive breastfeeding is nutritionally complete 
for term infants and results in optimal growth. Mother's 
milk contains nutrients of high biological value, 
stimulates the development of natural immunity, and 
is above all practical, economical, convenient, and 
rewarding because it stimulates the mother to child 
bonding. 
The digestive system of a newborn is immature. 
Infants may lose up to 10% of their birth weight in 
the first days of his life, as they adjust using their own 
digestive system. The optimal infant feeding need to 
contain a large amount of calories in a relatively small 
volume of food. Breast milk, with a high fat content, is 
the most efficient way for infants to meet their caloric 
needs.4
During the first 4-6 months of life, the digestive 
system undergoes enormous changes as it develops the 
ability to produce enzymes to digest food, to develop 
tolerance and antibodies offering protection. During 
first months of life, infants can not handle solid food 
or large feedings, because their intestinal tract is not 
suficiently developed and mature. Breast milk is a 
food designed especially for infants to allow adapted 
maturation of the gastrointestinal tract.
Lipase and bile salts, which aid in fat digestion, do 
not reach full levels until the age of 6 months. Human 
milk is rich in lipids (98% triglyceride), but contains 
bile salt-stimulated lipase which is an enzyme similar 
to pancreatic lipase.4,5 Proteins and amino acids are 
needed by infants in relatively important quantities to 
support their rapid growth rate. Protein requirements 
are met by adequate intake of breast milk. Breast milk 
contains a variety of proteases, including trypsin, 
elastase, plasmin, etc that start digesting proteins as 
soon as they are secreted. Breast milk also contains 
antiproteases that serve to protect milk proteins from 
degradation. The process of protein secretion and 
digestion in the mammary glands, depends on the 
balance of proteases and antiprotease.6 Unmodified 
cow’s milk is not suitable to feed an infant because 
it is nutrionally unbalanced, has a high renal solute 
load (three times as much protein as as human milk, 
an excess of sodium), too low in iron, and fat that is 
difficult to be digested by the infant's gastrointestinal 
system.
Gut Protection
Breast milk is important for the maturation of 
the infant’s digestive system. Colonies of beneficial 
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bacteria will develop in the intestine as a consequence 
of the presence of human milk oligosacchardes 
and intestinal grorwth fatcors in mother's milk. 
These beneficial bacteria help prevent an invasion 
by pathogens and contribute to a heatly maturation 
process. The protective mucosal barrier in infant 
is immature and puts infant at risk for infection. 
Antibodies in breast milk help protect infants until 
the digestive mucosa matures and increases the ability 
to produce its own antibodies around the age of 4-6 
months.
Secretory Immunoglobulin A (sIgA) constitutes the 
first line of defense, protecting the intestinal epithelium 
from enteric toxins and pathogenic microorganisms. 
sIgA promotes the clearance of antigens from the gut by 
blocking their access to epithelial receptors, entrapping 
in mucus, and facilitating their removal by peristaltic 
and mucociliary activities.7 sIgA in breast milk is 
capable of binding commensal bacteria and may be 
involved in the progressive and controlled establishment 
microbiota of the newborn. The microbiota stimulates 
the maturation of the gut-associated-lymphoid-tissue 
(GALT), resulting in the production of IgA with both 
a limited affinity and repertoire to redundant epitopes 
on gut microorganisms.8
Potentially protective factors are present in higher 
amounts in feces from breast-fed infant than from 
formula-fed infants. The sIgA level in breastmilk is 
high (1-2g /L in colostrum and 0.5-1 g/L in mature 
breastmilk). The sIgA levels in the feces of breastfed 
infants (0.11 + 0.07 mg/mL) was higher than in the 
feces of standard formula-fed infants (0.03 + 0.01 mg/
mL) at the age of one month of life.9
Gut bacteria modulate the immune response. The 
amount of intestinal bifidobacteria in breastfed infants 
is higher than in formula-fed babies. Mother's milk 
influences the specie sand amount of gut bacteria 
through multiple factors, such as human milk 
oligosaccharides, immunology active components, 
nutrient content (e.g low protein and low phosphate), 
etc. This microbiota will stimulate the reproduction of 
sIgA against some gastrointestinal pathogens such as 
E. coli, V. cholerae, C. difficile, Salmonella, Rotavirus, 
C. albicans.10
Good Reason for Breastfeeding 
Casein is a milk protein with diverse biologic 
consequences. What is good for the goose may be good 
for the gander, but what is good for the cow could be 
harmful to the human infant. The differences in protein 
fractions between human and cow milk are impressive. 
First, cow's milk contains three times more protein than 
human milk. Breast milk contains 60% whey and 40% 
casein while cow’s milk contains 20% whey and 80% 
casein. Whey breast milk contains mostly lactoferrin, 
alpha lactalbumin and immunoglobulin, whereas whey 
cow’s milk contains mostly Beta-lactoglobulin.11 A 
randomized clinical trial showed low protein in infant 
formula is associated with lower weight up to age 
2 year, more similar to the weight gain in breastfed 
infants.12,13 There is no convincing scientific evidence 
that avoidance or delayed introduction of potentially 
allergenic foods, such as fish and eggs would reduce 
allergies, either in infants considered at increased 
risk for the development of allergy or in those not 
considered to be at increased risk.14 If the incidence 
of allergic manifestaions is higher in formula than 
in breastfed infants, is still a matter of debated. This 
is mainly due to the fact that breatsfeeding cannot 
be randomized, and that the most allergic families 
breastfeed more frequently and longer. 
Mother's milk protects against infection because it 
contains different factors with immologic properties. 
Therefore, mothers milk influences the longterm 
immune response and risk for the development of 
auto-immune disease. sIgA, lactoferin, lysozym, 
lactoproxidase, oligosaccharides, bifidus factor, 
etc act as anti-microbial agents; cytokines (IL-10 
and TGFB) and anti-idiotypic antibodies play an 
important role in the development of tolerance and 
priming; macrophages, neutrophils, lymphocytes, 
cytokines, growth factors, hormones, nucleotides, milk 
peptide, adhesion molecules influence the immune 
development, and TNF alpha and Il-6 receptors CD4, 
cytokines, adhesion molecules, LC-PUFA, IL-1 
receptor antagonist, lactoferin, hormone and growth 
factors, etc. have anti-inflamatory properties.15
Lactoferrin is an iron binding protein, facilitating 
iron uptake, and is resistant to trypsin digestion. 
Lactoferin has a bacteriostatic effect since it has 
a high iron affinity and competition for iron with 
iron-dependant microbes. Lactoferrin has a strong 
bactericidal effect (independent from iron saturation), 
at least partly due to lactoferricin (bactericidal peptide 
formed during digestion). Lactoferrin also decreases 
the intestinal cell attachment of Enteropathogenic E. 
coli (EPEC). In vitro, lactoferricin is active against 
HIV and C. albicans.16
Essential fatty acids (e.g. linoleic acid, alpha 
linolenic acid) can not be synthesized by the body, must 
therefore be supplied in adequate amounts by feeding. 
Essensial fatty acids are precursors of a number of 
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long-chain poly-unsaturated fatty acids (LCPUFAs). 
The long-chain poly-unsaturated fatty acids consist 
of arachidonic acid (ARA) and Docosohexanoic acid 
(DHA). Arachidonic acid acts in all cell membran as 
modulator of cell immunity, and is pro-inflammatory. 
Docosohexanoic acid is present mainly in neuronal 
tissue (brain, retina) and has also an important role 
on the development of immune function, and has 
anti-inflammatory properties. The levels of DHA in 
human milk lipids reflect the dietary intake of the 
mother. World-wide, the mean ratio of ARA and 
DHA in human milk is 1: 1, what ensures an adequate 
ARA status even in presence of DHA. Excessive 
LC-PUFA supplementation may induce a risk for 
metabolic oxidation. ARA is efficiently metabolised 
from linoleic acid. Excesses of ARA may lead to 
undesirable inflammatory processes. Essential fatty 
acids may possibly enhance the beneficial actions of 
probiotics since LC-PUFAs promote the adhesion of 
probiotics to mucosal surfaces which increases their 
health-promoting.17 Some studies showed abnormal 
fatty acids composition in umbilical cord blood in 
infants at high risk of atopic diseases. Breast milk 
from mothers of children with newly developed atopic 
eczema has low levels of LC-PUFA.18,19
The human milk oligosaccharides are the third 
most important nutritional component after fat and 
lactose in human milk. Human milk oligosacharides 
act as receptor analogous for glycoconjugates on 
epithelial and endothelial cells. Glycolipids and 
glycoproteins mediate cell to cell interaction, bind 
humoral mediators, and modulate signal transfer. 
Human milk oligosacharides decrease the adhesion 
of invasive C. jejuni and the toxicity of heat stable 
E.coli enterotoxin.20 Human milk oligosacharides 
are fermented in the colon, found in stools. The 
bifidobacteria and lactobacilli present in the colon 
will ferment oligosaccharides into energy and short 
chain fatty acids (acetate, proprionate, butyrate), 
making the environment in the colon suitable for 
the growth of these bacteria. Lactic acid increases 
the motility and blood flow of the colon, stimulating 
the absorption of minerals. Butyric acid increases 
the proliferation of colonic epithelial cells and fluid 
absorption, and stimulates mucus production in the 
intestinal epithelium, while propionic acid decreases 
the inflammatory mediators.21
Nucleotides are conditionally essential nutrients for 
infants with beneficial effects on the immune system, 
lymphocyte maturation, antibody response to vaccines, 
increase of sIgA, and decrease the incidence of various 
infections, especially infections of gastrointestinal and 
upper respiratory tract.22 Nucleotides also respond 
better to diphtheria, polio and influenza immunization.23
CONCLUSION
Human milk is the best, complete nutrition for 
infants. It has anti-infective and anti-inflammatory 
effects by modulating the development of the immune 
response. Numerous human milk components and 
their interaction are involved in this complex process. 
Research is neeeded to better understand the short 
and longterm effects of these specific nutrients and 
breastfeeding as a whole. Opportunities for innovations 
in infant formula exist since many outcomes in 
formula-fed infants differ from those in breastfed 
populations. The development of these innovations 
with relevant outcome effects is complex, costly and 
time consuming. 
REFERENCES
1. Kramer MS, Kakuma R. The optimal duration of exclusive 
breastfeeding: a systemic review. World Health Organization 
2002:14-20.
2. Doughty D. Structure and function of the gastrointestinal 
tract in infants and children. J Wound Ostomy Continence 
Nurs 2004;31:207-12.
3. Bartick M, Reinhold A. The burden of suboptimal breastfeeding 
in the United States: a pediatric cost analysis. Pediatrics 
2010;125:e1048-56.
4. Abrahamse E, Minekus M, van Aken GA, van de Heijning 
B, Knol J, Bartke N, et al. Development of the digestive 
system-experimental challenges and approaches of infant 
lipid digestion. Food Dig 2012;3:63–77.
5. Lindquist S, Hernell O. Lipid digestion and absorption 
in early life: an update. Curr Opin Clin Nutr Metab Care 
2012;13:314–20.
6. Dallas DC, Underwood MA, Zivkovic AM, German GB. 
Digestion of protein in premature and term infants. J Nutr 
Disorders Ther 2012;2:112.
7. Mantis NJ, Roi N. Secretory IgA's complex roles in immunity 
and mucosal homeostasis in the gut. Mucosal Immunol 
2011;4:603-11.
8. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota 
in health and disease. Physiol Rev 2010;90:859-904.
9. Köhler H, Donarski S, Stocks B. Antibacterial characteristics 
in the feces of breast-fed and formula-fed infants during the 
first year of life. J Pediatr Gastroenterol Nutr 2002;34:188-93.
10. Walter J, Ley RE. The human gut microbiome: ecology 
and recent evolutionary changes. Annu Rev Microbiol 
2011;65:411-29. 
11. Miller MJ, Witherly SA, Clark DA. Casein: a milk protein 
with diverse biologic consequences. Proc Soc Exp Biol Med 
1990;195:143-59.
12. Escribano J, Luque V, Ferre N. Increased protein intake 
augments kidney volume and function in healthy infants. 
Kidney Int 2011;79:783-90.
The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy46
Badriul Hegar, Yvan Vandenplas
13. Koletzko B , Closa R, Lower protein in infant formula is 
associated with lower weight up to age 2 y: a randomized 
clinical trial. Am J Clin Nutr 2009;89:1836-45.
14. Agostoni C, Decsi T, Fewtrell M. Complementary feeding: 
a commentary by the ESPGHAN Committee on Nutrition. J 
Pediatr Gastroenterol Nutr 2008;46:99-110.
15. Field CJ. The immunological components of human milk 
and their effect on immune development in infants. CJJ Nutr 
2005;135:1-4.
16. Edde L, Hipolito RB, Hwang FF. Lactoferrin protects neonatal 
rats from gut-related systemic infection. Am J Physiol 
Gastrointest Liver Physiol 2001;281:G1140-50.
17. Das UN. Nutrition 2002;18:786-9.
18. Beck M, Zelczak G, Lentze MJ. Abnormal fatty acid 
composition in umbilical cord blood of infants at high risk of 
atopic disease. Acta Paediatr 2000;89:279-84.
19. Businco L, Ioppi M, Morse NL, Nisini R, Wright S. Breast 
milk from mothers of children with newly developed atopic 
eczema has low levels of long chain polyunsaturated fatty 
acids. J Allergy Clin Immunol 1993;91:1134-9.
20. Newburg DS, Shen Z, Warren CD. Quantitative analysis of 
human milk oligosaccharides by capillary electrophoresis. 
Adv Exp Med Biol 2000;478:381-2.
21. Guarner FI, Malagelada JR. Gut flora in health and disease. 
Lancet 2003;361:512-9.
22. Schaller JP. Seminars in Fetal Medicine 2007;12:35-44.
23. Gutiérrez CP, Mora MI, Díaz-García L, Immune response to 
nucleotide-supplemented infant formulae: systematic review 
and meta-analysis. Br J Nutr 2007;98:S64.
